bupropion hydrochloride (sr) (43598-863)

Drug Facts

Product Profile

Brand Name bupropion hydrochloride (sr)

Generic Name bupropion hydrochloride

Labeler dr. reddy's laboratories inc

Dosage Form TABLET, EXTENDED RELEASE

Routes

ORAL

Active Ingredients

bupropion hydrochloride 150 mg/1

Manufacturer

Dr. Reddy's Laboratories Inc

Identifiers & Regulatory

Product NDC 43598-863

Product ID 43598-863_4486fd29-bab2-59ee-e063-6294a90a4fd2

Product Type HUMAN PRESCRIPTION DRUG

Marketing Category ANDA

Application Number ANDA206122

Listing Expiration 2026-12-31

Marketing Start 2016-08-17

Pharmacologic Class

Classes

aminoketone [epc] dopamine uptake inhibitors [moa] increased dopamine activity [pe] increased norepinephrine activity [pe] norepinephrine uptake inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 43598863

Hyphenated Format 43598-863

Supplemental Identifiers

RxCUI

1801289

UPC

0343598863603

UNII

ZG7E5POY8O

Packaging Origin

Original Packager

true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name bupropion hydrochloride (sr) (source: ndc)

Generic Name bupropion hydrochloride (source: ndc)

Application Number ANDA206122 (source: ndc)

Routes

ORAL

source: ndc

Resolved Composition

Strengths

150 mg/1

source: ndc

Packaging

1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (43598-863-10)
30 TABLET, EXTENDED RELEASE in 1 BOTTLE (43598-863-30)
60 TABLET, EXTENDED RELEASE in 1 BOTTLE (43598-863-60)

source: ndc

Packages (3)

43598-863-10 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (43598-863-10) 43598-863-30 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (43598-863-30) 43598-863-60 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (43598-863-60)

Ingredients (1)

bupropion hydrochloride (150 mg/1)

Linked Drug Pages (1)

BUPROPION HYDROCHLORIDE (SR) ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload

{"route": ["ORAL"], "spl_id": "4486fd29-bab2-59ee-e063-6294a90a4fd2", "openfda": {"upc": ["0343598863603"], "unii": ["ZG7E5POY8O"], "rxcui": ["1801289"], "spl_set_id": ["8069c521-c49a-4b6d-baa8-4b0be897d585"], "manufacturer_name": ["Dr. Reddy's Laboratories Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (43598-863-10)", "package_ndc": "43598-863-10", "marketing_start_date": "20160817"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (43598-863-30)", "package_ndc": "43598-863-30", "marketing_start_date": "20160817"}, {"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (43598-863-60)", "package_ndc": "43598-863-60", "marketing_start_date": "20160817"}], "brand_name": "BUPROPION HYDROCHLORIDE (SR)", "product_id": "43598-863_4486fd29-bab2-59ee-e063-6294a90a4fd2", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "43598-863", "generic_name": "Bupropion Hydrochloride", "labeler_name": "Dr. Reddy's Laboratories Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BUPROPION HYDROCHLORIDE (SR)", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA206122", "marketing_category": "ANDA", "marketing_start_date": "20160817", "listing_expiration_date": "20261231"}